Pharmaceuticals Citations 1-374 of 374 total displayed. Most recent content (1 Nov 2009): Anil Soni and Rajat Gupta Bridging The Resource Gap: Improving Value For Money In HIV/AIDS Treatment Health Affairs, November/December 2009; 28(6): 1617-1628. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Past content (since Feb 1983): Kevin Outterson and Aaron S. Kesselheim How Medicare Could Get Better Prices On Prescription Drugs Health Affairs, September/October 2009; 28(5): w832-w841. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Tahir Amin, Rahul Rajkumar, Priti Radhakrishnan, and Aaron S. Kesselheim Expert Review Of Drug Patent Applications: Improving Health In The Developing World Health Affairs, September/October 2009; 28(5): w948-w956. [Abstract] [Full Text] [PDF] [Table Of Contents] [Reprints & Permissions] Ellen R. Shaffer and Joseph E. Brenner A Trade Agreement’s Impact On Access To Generic Drugs Health Affairs, September/October 2009; 28(5): w957-w968. [Abstract] [Full Text] [PDF] [Appendix] [Reprints & Permissions] Donald W. Light Global Drug Discovery: Europe Is Ahead Health Affairs, September/October 2009; 28(5): w969-w977. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] M. Kate Bundorf, Anne Royalty, and Laurence C. Baker Health Care Cost Growth Among The Privately Insured Health Affairs, September/October 2009; 28(5): 1294-1304. [Abstract] [Full Text] [Figures Only] [PDF] [Technical Appendix][Erratum] [Reprints & Permissions] Mark V. Pauly Is It Time To Reexamine The Patent System’s Role In Spending Growth? Health Affairs, September/October 2009; 28(5): 1466-1474. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Ramanan Laxminarayan and Hellen Gelband A Global Subsidy: Key To Affordable Drugs For Malaria? Health Affairs, July/August 2009; 28(4): 949-961. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Laura J. Frost and Michael R. Reich Creating Access To Health Technologies In Poor Countries Health Affairs, July/August 2009; 28(4): 962-973. [Abstract] [Full Text] [Figures Only] [PDF] [Supplemental Exhibit] [Reprints & Permissions] Chris D. James, John Peabody, Orville Solon, Stella Quimbo, and Kara Hanson An Unhealthy Public-Private Tension: Pharmacy Ownership, Prescribing, And Spending In The Philippines Health Affairs, July/August 2009; 28(4): 1022-1033. [Abstract] [Full Text] [PDF] [Supplemental Exhibit] [Reprints & Permissions] Amy Stewart Nunn, Elize Massard da Fonseca, Francisco I. Bastos, and Sofia Gruskin AIDS Treatment In Brazil: Impacts And Challenges Health Affairs, July/August 2009; 28(4): 1103-1113. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Susan Dentzer Eliminating Neglected Diseases In Poor Countries: A Conversation With Andrew Witty Health Affairs, May/June 2009; 28(3): w411-w416. [Extract] [Full Text] [PDF] [Reprints & Permissions] Pharmaceuticals & Psychotropic Drugs Health Affairs, May/June 2009; 28(3): 723 [Extract] [Full Text] [PDF] [Reprints & Permissions] Susan H. Busch and Colleen L. Barry Pediatric Antidepressant Use After The Black-Box Warning Health Affairs, May/June 2009; 28(3): 724-733. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Haiden A. Huskamp, Alisa B. Busch, Marisa E. Domino, and Sharon-Lise T. Normand Antidepressant Reformulations: Who Uses Them, And What Are The Benefits? Health Affairs, May/June 2009; 28(3): 734-745. [Abstract] [Full Text] [PDF] [Appendix] [Reprints & Permissions] Julie M. Donohue, Haiden A. Huskamp, and Samuel H. Zuvekas Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring? Health Affairs, May/June 2009; 28(3): 746-759. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Niteesh K. Choudhry, Joy L. Lee, Jessica Agnew-Blais, Colleen Corcoran, and William H. Shrank Drug Company–Sponsored Patient Assistance Programs: A Viable Safety Net? Health Affairs, May/June 2009; 28(3): 827-834. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Ken Johnson Voluntary Patient Assistance Programs: Additional Federal Oversight Unwarranted Health Affairs, May/June 2009; 28(3): 835-838. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Myrl Weinberg Reforming Patient Assistance Programs: Perfect World Meets Real World Health Affairs, May/June 2009; 28(3): 839-842. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Niteesh K. Choudhry, Joy L. Lee, Jessica Agnew-Blais, Colleen Corcoran, and William H. Shrank Patient Assistance Programs: Information Is Not Our Enemy Health Affairs, May/June 2009; 28(3): 843-844. [Extract] [Full Text] [PDF] [Reprints & Permissions] Sebastian Schneeweiss, Amanda R. Patrick, Alex Pedan, Laleh Varasteh, Raisa Levin, Nan Liu, and William H. Shrank The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits Health Affairs, March/April 2009; 28(2): w305-w316. [Abstract] [Full Text] [Figures Only] [PDF] [Schematic] [Reprints & Permissions] Yuting Zhang, Julie Marie Donohue, Joseph P. Newhouse, and Judith R. Lave The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D Health Affairs, March/April 2009; 28(2): w317-w325. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Andrea Sisko, Christopher Truffer, Sheila Smith, Sean Keehan, Jonathan Cylus, John A. Poisal, M. Kent Clemens, and Joseph Lizonitz Health Spending Projections Through 2018: Recession Effects Add Uncertainty To The Outlook Health Affairs, March/April 2009; 28(2): w346-w357. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Maria A. Friedman, Anthony Schueth, and Douglas S. Bell Interoperable Electronic Prescribing In The United States: A Progress Report Health Affairs, March/April 2009; 28(2): 393-403. [Abstract] [Full Text] [PDF] [Appendix Exhibits] [Reprints & Permissions] Melinda Morton Buying Lunch...And What Else? Health Affairs, March/April 2009; 28(2): 540-545. [Extract] [Full Text] [PDF] [Listen to the Author] [Reprints & Permissions] William H. Shrank, Emily R. Cox, Michael A. Fischer, Jyotsna Mehta, and Niteesh K. Choudhry Patients’ Perceptions Of Generic Medications Health Affairs, March/April 2009; 28(2): 546-556. [Abstract] [Full Text] [Figures Only] [PDF] [Survey Instrument & Supp. Exhibit 4] [Reprints & Permissions] Neeraj Sood, Han de Vries, Italo Gutierrez, Darius N. Lakdawalla, and Dana P. Goldman The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries Health Affairs, January/February 2009; 28(1): w125-w137. [Abstract] [Full Text] [Figures Only] [PDF] [Appendices][Table Of Contents] [Reprints & Permissions] Darius N. Lakdawalla, Dana P. Goldman, Pierre-Carl Michaud, Neeraj Sood, Robert Lempert, Ze Cong, Han de Vries, and Italo Gutierrez U.S. Pharmaceutical Policy In A Global Marketplace Health Affairs, January/February 2009; 28(1): w138-w150. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix] [Reprints & Permissions] Murray Aitken, Ernst R. Berndt, and David M. Cutler Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point Health Affairs, January/February 2009; 28(1): w151-w160. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] F.M. Scherer Price Controls And Global Pharmaceutical Progress Health Affairs, January/February 2009; 28(1): w161-w164. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Arjun Jayadev and Joseph Stiglitz Two Ideas To Increase Innovation And Reduce Pharmaceutical Costs And Prices Health Affairs, January/February 2009; 28(1): w165-w168. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John Hsu, Jie Huang, Vicki Fung, Mary Price, Richard Brand, Rita Hui, Bruce Fireman, William Dow, John Bertko, and Joseph P. Newhouse Distributing $800 Billion: An Early Assessment Of Medicare Part D Risk Adjustment Health Affairs, January/February 2009; 28(1): 215-225. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix Exhibits] [Reprints & Permissions] Micah Hartman, Anne Martin, Patricia McDonnell, Aaron Catlin the National Health Expenditure Accounts Team National Health Spending In 2007: Slower Drug Spending Contributes To Lowest Rate Of Overall Growth Since 1998 Health Affairs, January/February 2009; 28(1): 246-261. [Abstract] [Full Text] [PDF] [Erratum] [Reprints & Permissions] Brian Garriock Firth, Liesl M. Cooper, and Steve Fearn The Appropriate Role Of Cost-Effectiveness In Determining Device Coverage: A Case Study Of Drug-Eluting Stents Health Affairs, November/December 2008; 27(6): 1577-1586. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix Figures] [Reprints & Permissions] Shelby D. Reed, Kevin J. Anstrom, Damon M. Seils, Robert M. Califf, and Kevin A. Schulman Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs Health Affairs, September/October 2008; 27(5): w360-w370. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix and Disclosures] [Reprints & Permissions] Hak-Ju Kim and Jennifer Prah Ruger Pharmaceutical Reform In South Korea And The Lessons It Provides Health Affairs, July/August 2008; 27(4): w260-w269. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Barbara J. Culliton Nanomedicine—The Power Of Proteins: A Conversation With Lance Liotta And Emanual Petricoin Health Affairs, July/August 2008; 27(4): w310-w314. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Barbara J. Culliton Is Special FDA Regulation Of Nanomedicine Needed? A Conversation With Norris E. Alderson Health Affairs, July/August 2008; 27(4): w315-w317. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bo Zhou, Li Yang, Qingmin Sun, Haijuan Gu, and Bin Wang Social Health Insurance And Drug Spending Among Cancer Inpatients In China Health Affairs, July/August 2008; 27(4): 1020-1027. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Biotechnology And Drugs Health Affairs, July/August 2008; 27(4): 1028 [Extract] [Full Text] [PDF] [Reprints & Permissions] Sarah E. Frew, Hannah E. Kettler, and Peter A. Singer The Indian And Chinese Health Biotechnology Industries: Potential Champions Of Global Health? Health Affairs, July/August 2008; 27(4): 1029-1041. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Qiang Sun, Michael A. Santoro, Qingyue Meng, Caitlin Liu, and Karen Eggleston Pharmaceutical Policy In China Health Affairs, July/August 2008; 27(4): 1042-1050. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Renslow Sherer, Xien Gui, Faxian Zhan, Caroline Teter, Diana Liu Ping, and Randolph F. Wykoff Rapid Antiretroviral Therapy Scale-Up In Hubei Province, China Health Affairs, July/August 2008; 27(4): 1140-1147. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Stephen B. Soumerai, Fang Zhang, Dennis Ross-Degnan, Daniel E. Ball, Robert F. LeCates, Michael R. Law, Tom E. Hughes, Daniel Chapman, and Alyce S. Adams Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change Health Affairs, May/June 2008; 27(3): w185-w195. [Abstract] [Full Text] [Figures Only] [PDF] [Online Appendix] [Reprints & Permissions] Vincent J. Willey, Michael F. Pollack, Wayne M. Lednar, William N. Yang, Charles Kennedy, and Grant Lawless Costs Of Severely Ill Members And Specialty Medication Use In A Commercially Insured Population Health Affairs, May/June 2008; 27(3): 824-834. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Michael F. Furukawa, T.S. Raghu, Trent J. Spaulding, and Ajay Vinze Adoption Of Health Information Technology For Medication Safety In U.S. Hospitals, 2006 Health Affairs, May/June 2008; 27(3): 865-875. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix Exhibits] [Reprints & Permissions] Sean Keehan, Andrea Sisko, Christopher Truffer, Sheila Smith, Cathy Cowan, John Poisal, M. Kent Clemens the National Health Expenditure Accounts Projections Team Health Spending Projections Through 2017: The Baby-Boom Generation Is Coming To Medicare Health Affairs, March/April 2008; 27(2): w145-w155. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Haiden A. Huskamp, David G. Stevenson, Nancy L. Keating, and Joseph P. Newhouse Rejections Of Drug Claims For Nursing Home Residents Under Medicare Part D Health Affairs, March/April 2008; 27(2): 560-567. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Aaron Catlin, Cathy Cowan, Micah Hartman, Stephen Heffler the National Health Expenditure Accounts Team National Health Spending In 2006: A Year Of Change For Prescription Drugs Health Affairs, January/February 2008; 27(1): 14-29. [Abstract] [Full Text] [Figures Only] [PDF] [Erratum] [Reprints & Permissions] Paul B. Ginsburg Don’t Break Out The Champagne: Continued Slowing Of Health Care Spending Growth Unlikely To Last Health Affairs, January/February 2008; 27(1): 30-32. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Richard G. Frank and Joseph P. Newhouse Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? Health Affairs, January/February 2008; 27(1): 33-43. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Richard A. Hirth, Scott L. Greer, Justin M. Albert, Eric W. Young, and John D. Piette Out-Of-Pocket Spending And Medication Adherence Among Dialysis Patients In Twelve Countries Health Affairs, January/February 2008; 27(1): 89-102. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Assuring Access To Affordable Drugs And Vaccines Health Affairs, January/February 2008; 27(1): 121 [Extract] [Full Text] [PDF] [Reprints & Permissions] Dana P. Goldman, Anupam B. Jena, Tomas Philipson, and Eric Sun Drug Licenses: A New Model For Pharmaceutical Pricing Health Affairs, January/February 2008; 27(1): 122-129. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bong-min Yang, Eun-young Bae, and Jinhyun Kim Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea’s National Health Insurance Health Affairs, January/February 2008; 27(1): 179-187. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Brian K. Bruen and Laura M. Miller Changes In Medicaid Prescription Volume And Use In The Wake Of Medicare Part D Implementation Health Affairs, January/February 2008; 27(1): 196-202. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Ray Bingham The Face-Off Health Affairs, January/February 2008; 27(1): 210-215. [Extract] [Full Text] [PDF] [Reprints & Permissions] Patricia M. Danzon and Michael F. Furukawa International Prices And Availability Of Pharmaceuticals In 2005 Health Affairs, January/February 2008; 27(1): 221-233. [Abstract] [Full Text] [PDF] [Online Appendix] [Reprints & Permissions] Kenneth E. Thorpe, David H. Howard, and Katya Galactionova Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap Health Affairs, November/December 2007; 26(6): w678-w686. [Abstract] [Full Text] [PDF] [Technical Appendix] [Reprints & Permissions] Ruth Lopert and Marilyn Moon Toward A Rational, Value-Based Drug Benefit For Medicare Health Affairs, November/December 2007; 26(6): 1666-1673. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Frank R. Lichtenberg and Shawn X. Sun The Impact Of Medicare Part D On Prescription Drug Use By The Elderly Health Affairs, November/December 2007; 26(6): 1735-1744. [Abstract] [Full Text] [Figures Only] [PDF] [Technical Appendix] [Reprints & Permissions] Patricia Neuman, Michelle Kitchman Strollo, Stuart Guterman, William H. Rogers, Angela Li, Angie Mae C. Rodday, and Dana Gelb Safran Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors Health Affairs, September/October 2007; 26(5): w630-w643. [Abstract] [Full Text] [Figures Only] [PDF] [Online Exhibit][Interview With The Author] [Reprints & Permissions] Geoffrey F. Joyce, Dana P. Goldman, Pinar Karaca-Mandic, and Yuhui Zheng Pharmacy Benefit Caps And The Chronically Ill Health Affairs, September/October 2007; 26(5): 1333-1344. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Margaret K. Kyle and David B. Ridley Would Greater Transparency And Uniformity Of Health Care Prices Benefit Poor Patients? Health Affairs, September/October 2007; 26(5): 1384-1391. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Alexander Kallen, Steven Woloshin, Jennifer Shu, Ellen Juhl, and Lisa Schwartz Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress Report Health Affairs, September/October 2007; 26(5): 1392-1398. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Marsha Gold Medicare Advantage In 2006–2007: What Congress Intended? Health Affairs, July/August 2007; 26(4): w445-w455. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Joy M. Grossman, Anneliese Gerland, Marie C. Reed, and Cheryl Fahlman Physicians’ Experiences Using Commercial E-Prescribing Systems Health Affairs, May/June 2007; 26(3): w393-w404. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John K. Iglehart Pursuing Medical Progress: Managing Benefits And Risks Health Affairs, May/June 2007; 26(3): 623 [Extract] [Full Text] [PDF] [Reprints & Permissions] Risks, Benefits, And Uncertainty In Health Care Health Affairs, May/June 2007; 26(3): 624 [Extract] [Full Text] [PDF] [Reprints & Permissions] John Graham and Jianhui Hu The Risk-Benefit Balance In The United States: Who Decides? Health Affairs, May/June 2007; 26(3): 625-635. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Joshua T. Cohen and Peter J. Neumann What’s More Dangerous, Your Aspirin Or Your Car? Thinking Rationally About Drug Risks (And Benefits) Health Affairs, May/June 2007; 26(3): 636-646. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Peter Juhn, Audrey Phillips, and Kathy Buto Balancing Modern Medical Benefits And Risks Health Affairs, May/June 2007; 26(3): 647-652. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Mark V. Pauly Risks And Benefits In Health Care: The View From Economics Health Affairs, May/June 2007; 26(3): 653-662. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Regulatory Tools And Incentives For Dealing With Health-Related Risk Health Affairs, May/June 2007; 26(3): 663 [Extract] [Full Text] [PDF] [Reprints & Permissions] Scott Gottlieb Drug Safety Proposals And The Intrusion Of Federal Regulation Into Patient Freedom And Medical Practice Health Affairs, May/June 2007; 26(3): 664-677. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Michael B. Enzi and Edward M. Kennedy Risk Management And Intrusions On Medical Practice: Striking A Balance Health Affairs, May/June 2007; 26(3): 678-680. [Abstract] [Full Text] [PDF] [Reprints & Permissions] David Meltzer Risks And Benefits Of Risk-Management Plans Health Affairs, May/June 2007; 26(3): 681-683. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Louis P. Garrison, Jr., Adrian Towse, and Brian W. Bresnahan Assessing A Structured, Quantitative Health Outcomes Approach To Drug Risk-Benefit Analysis Health Affairs, May/June 2007; 26(3): 684-695. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Anupam B. Jena and Tomas Philipson Cost-Effectiveness As A Price Control Health Affairs, May/June 2007; 26(3): 696-703. [Abstract] [Full Text] [PDF] [Reprints & Permissions] William H. Shrank and Jerry Avorn Educating Patients About Their Medications: The Potential And Limitations Of Written Drug Information Health Affairs, May/June 2007; 26(3): 731-740. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Jennifer M. Polinski, Philip S. Wang, and Michael A. Fischer Medicaid’s Prior Authorization Program And Access To Atypical Antipsychotic Medications Health Affairs, May/June 2007; 26(3): 750-760. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Steven J. Katz and Sarah T. Hawley From Policy To Patients And Back: Surgical Treatment Decision Making For Patients With Breast Cancer Health Affairs, May/June 2007; 26(3): 761-769. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Ernst R. Berndt, Richard Mortimer, Ashoke Bhattacharjya, Andrew Parece, and Edward Tuttle Authorized Generic Drugs, Price Competition, And Consumers’ Welfare Health Affairs, May/June 2007; 26(3): 790-799. [Abstract] [Full Text] [Figures Only] [PDF] [Online Supplement] [Reprints & Permissions] Michael A. Fischer, Niteesh K. Choudhry, and Wolfgang C. Winkelmayer Impact Of Medicaid Prior Authorization On Angiotensin-Receptor Blockers: Can Policy Promote Rational Prescribing? Health Affairs, May/June 2007; 26(3): 800-807. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Joel J. Davis Consumers’ Preferences For The Communication Of Risk Information In Drug Advertising Health Affairs, May/June 2007; 26(3): 863-870. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Yuting Zhang and Stephen B. Soumerai Do Newer Prescription Drugs Pay For Themselves? A Reassessment Of The Evidence Health Affairs, May/June 2007; 26(3): 880-886. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Frank R. Lichtenberg Effects Of New Drugs On Overall Health Spending: Frank Lichtenberg Responds Health Affairs, May/June 2007; 26(3): 887-890. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John A. Poisal, Christopher Truffer, Sheila Smith, Andrea Sisko, Cathy Cowan, Sean Keehan, Bridget Dickensheets the National Health Expenditure Accounts Projections Team Health Spending Projections Through 2016: Modest Changes Obscure Part D’s Impact Health Affairs, March/April 2007; 26(2): w242-w253. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Richard M. Scheffler, Stephen P. Hinshaw, Sepideh Modrek, and Peter Levine The Global Market For ADHD Medications Health Affairs, March/April 2007; 26(2): 450-457. [Abstract] [Full Text] [Figures Only] [PDF] [Supplemental Exhibits] [Reprints & Permissions] Aaron S. Kesselheim and Michelle M. Mello Confidentiality Laws And Secrecy In Medical Research: Improving Public Access To Data On Drug Safety Health Affairs, March/April 2007; 26(2): 483-491. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] John D. Lantos The Edge Of The Known World Health Affairs, March/April 2007; 26(2): 510-514. [Extract] [Full Text] [PDF] [Reprints & Permissions] Myron L. Weisfeldt and Susan J. Zieman Advances In The Prevention And Treatment Of Cardiovascular Disease Health Affairs, January/February 2007; 26(1): 25-37. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] David M. Cutler, Genia Long, Ernst R. Berndt, Jimmy Royer, Andrée-Anne Fournier, Alicia Sasser, and Pierre Cremieux The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation Health Affairs, January/February 2007; 26(1): 97-110. [Abstract] [Full Text] [Figures Only] [PDF] [Technical Appendix] [Reprints & Permissions] Aaron Catlin, Cathy Cowan, Stephen Heffler, Benjamin Washington the National Health Expenditure Accounts Team National Health Spending In 2005: The Slowdown Continues Health Affairs, January/February 2007; 26(1): 142-153. [Abstract] [Full Text] [Figures Only] [PDF] [Erratum] [Reprints & Permissions] Niteesh K. Choudhry, Jerry Avorn, Elliott M. Antman, Sebastian Schneeweiss, and William H. Shrank Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An Economic Analysis Health Affairs, January/February 2007; 26(1): 186-194. [Abstract] [Full Text] [Figures Only] [PDF] [Supplemental Exhibit] [Reprints & Permissions] Jonathan D. Ketcham, Laurence C. Baker, and Donna MacIsaac Physician Practice Size And Variations In Treatments And Outcomes: Evidence From Medicare Patients With AMI Health Affairs, January/February 2007; 26(1): 195-205. [Abstract] [Full Text] [PDF] [Appendix] [Reprints & Permissions] Samuel H. Zuvekas and Joel W. Cohen Prescription Drugs And The Changing Concentration Of Health Care Expenditures Health Affairs, January/February 2007; 26(1): 249-257. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Paul B. Ginsburg, Bradley C. Strunk, Michelle I. Banker, and John P. Cookson Tracking Health Care Costs: Continued Stability But At High Rates In 2005 Health Affairs, November/December 2006; 25(6): w486-w495. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Aaron S. Kesselheim, Michael A. Fischer, and Jerry Avorn Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending Health Affairs, November/December 2006; 25(6): 1637-1647. [Abstract] [Full Text] [Figures Only] [PDF] [Online Appendices][Erratum] [Reprints & Permissions] John K. Iglehart Biotech Drugs Come Of Age; Policymakers Take Notice Health Affairs, September/October 2006; 25(5): 1202-1203. [Extract] [Full Text] [PDF] [Reprints & Permissions] Insurance Coverage Of Biopharmaceuticals Health Affairs, September/October 2006; 25(5): 1204 [Extract] [Full Text] [PDF] [Reprints & Permissions] James C. Robinson Insurers’ Strategies For Managing The Use And Cost Of Biopharmaceuticals Health Affairs, September/October 2006; 25(5): 1205-1217. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Sean R. Tunis and Steven D. Pearson Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’ Health Affairs, September/October 2006; 25(5): 1218-1230. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Tanisha Carino, Reginald D. Williams, II, Allison M. Colbert, and Perry Bridger Medicare’s Coverage Of Colorectal Cancer Drugs: A Case Study In Evidence Development And Policy Health Affairs, September/October 2006; 25(5): 1231-1239. [Abstract] [Full Text] [PDF] [Erratum] [Reprints & Permissions] Jennifer Bowman, Amy Rousseau, David Silk, and Catherine Harrison Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006 Health Affairs, September/October 2006; 25(5): 1240-1248. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Dennis Cotter, Mae Thamer, Krishnan Narasimhan, Yi Zhang, and Kim Bullock Translating Epoetin Research Into Practice: The Role Of Government And The Use Of Scientific Evidence Health Affairs, September/October 2006; 25(5): 1249-1259. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Patricia Seliger Keenan, Peter J. Neumann, and Kathryn A. Phillips Biotechnology And Medicare’s New Technology Policy: Lessons From Three Case Studies Health Affairs, September/October 2006; 25(5): 1260-1269. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Evolution And Future Of Biopharmaceuticals Health Affairs, September/October 2006; 25(5): 1270 [Extract] [Full Text] [PDF] [Reprints & Permissions] Kathryn A. Phillips The Intersection Of Biotechnology And Pharmacogenomics: Health Policy Implications Health Affairs, September/October 2006; 25(5): 1271-1280. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Louis P. Garrison, Jr. and M.J. Finley Austin Linking Pharmacogenetics-Based Diagnostics And Drugs For Personalized Medicine Health Affairs, September/October 2006; 25(5): 1281-1290. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Henry Grabowski, Iain Cockburn, and Genia Long The Market For Follow-On Biologics: How Will It Evolve? Health Affairs, September/October 2006; 25(5): 1291-1301. [Abstract] [Full Text] [PDF] [Online Appendix] [Reprints & Permissions] John E. Calfee and Elizabeth DuPré The Emerging Market Dynamics Of Targeted Therapeutics Health Affairs, September/October 2006; 25(5): 1302-1308. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Shelby D. Reed, Robert M. Califf, and Kevin A. Schulman How Changes In Drug-Safety Regulations Affect The Way Drug And Biotech Companies Invest In Innovation Health Affairs, September/October 2006; 25(5): 1309-1317. [Abstract] [Full Text] [Figures Only] [PDF] [Online Technical Appendix] [Reprints & Permissions] Specialty Drug Management Health Affairs, September/October 2006; 25(5): 1318 [Extract] [Full Text] [PDF] [Reprints & Permissions] Dana P. Goldman, Geoffrey F. Joyce, Grant Lawless, William H. Crown, and Vincent Willey Benefit Design And Specialty Drug Use Health Affairs, September/October 2006; 25(5): 1319-1331. [Abstract] [Full Text] [Figures Only] [PDF] [Online Technical Appendix] [Reprints & Permissions] C. Daniel Mullins, Danielle Chauncey Lavallee, Françoise G. Pradel, Andrea R. DeVries, and Nadine Caputo Health Plans’ Strategies For Managing Outpatient Specialty Pharmaceuticals Health Affairs, September/October 2006; 25(5): 1332-1339. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] C. Douglas Monroe, Lori Potter, Mirta Millares, Anthony Barrueta, and Richard Wagner Kaiser Permanente’s Evaluation And Management Of Biotech Drugs: Assessing, Measuring, And Affecting Use Health Affairs, September/October 2006; 25(5): 1340-1346. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John B. Watkins, Sanchita Roy Choudhury, Ed Wong, and Sean D. Sullivan Managing Biotechnology In A Network-Model Health Plan: A U.S. Private Payer Perspective Health Affairs, September/October 2006; 25(5): 1347-1352. [Abstract] [Full Text] [PDF] [Online Exhibit] [Reprints & Permissions] Patricia M. Danzon and Michael F. Furukawa Prices And Availability Of Biopharmaceuticals: An International Comparison Health Affairs, September/October 2006; 25(5): 1353-1362. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix Exhibits] [Reprints & Permissions] Françoise Simon Market Access For Biopharmaceuticals: New Challenges Health Affairs, September/October 2006; 25(5): 1363-1370. [Abstract] [Full Text] [PDF] [Reprints & Permissions] W. David Bradford, Andrew N. Kleit, Paul J. Nietert, Terrence Steyer, Thomas McIlwain, and Steven Ornstein How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians’ Prescribing Behavior Health Affairs, September/October 2006; 25(5): 1371-1377. [Abstract] [Full Text] [Figures Only] [PDF] [Online Supplemental Exhibits] [Reprints & Permissions] Daniel M. Hartung, Kathy L. Ketchum, and Dean G. Haxby An Evaluation Of Oregon’s Evidence-Based Practitioner-Managed Prescription Drug Plan Health Affairs, September/October 2006; 25(5): 1423-1432. [Abstract] [Full Text] [Figures Only] [PDF] [Appendix] [Reprints & Permissions] J. Michael Paterson, Andreas Laupacis, Ken Bassett, Geoffrey M. Anderson for the BC-Ontario Pharmacosurveillance for Decision-Making Collaborative Using Pharmacoepidemiology To Inform Drug Coverage Policy: Initial Lessons From A Two-Province Collaborative Health Affairs, September/October 2006; 25(5): 1436-1443. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Austin B. Frakt and Steven D. Pizer A First Look At The New Medicare Prescription Drug Plans Health Affairs, July/August 2006; 25(4): w252-w261. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Peter J. Neumann Emerging Lessons From The Drug Effectiveness Review Project Health Affairs, July/August 2006; 25(4): w262-w271. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Mark Gibson and John Santa The Drug Effectiveness Review Project: An Important Step Forward Health Affairs, July/August 2006; 25(4): w272-w275. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Alan H. Heaton The DERP: Is It An Effective Methodology? Health Affairs, July/August 2006; 25(4): w276-w278. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Newell E. McElwee, S. Yin Ho, Kimberly A. McGuigan, and Mark L. Horn Evidence-Based Coverage Decisions? Primum Non Nocere Health Affairs, July/August 2006; 25(4): w279-w282. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Steven D. Findlay Bringing The DERP To Consumers: ‘Consumer Reports Best Buy Drugs’ Health Affairs, July/August 2006; 25(4): w283-w286. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Aaron S. Kesselheim, Michael A. Fischer, and Jerry Avorn The Rise And Fall Of Natrecor For Congestive Heart Failure: Implications For Drug Policy Health Affairs, July/August 2006; 25(4): 1095-1102. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Haiden A. Huskamp Prices, Profits, And Innovation: Examining Criticisms Of New Psychotropic Drugs’ Value Health Affairs, May/June 2006; 25(3): 635-646. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Julie Donohue Mental Health In The Medicare Part D Drug Benefit: A New Regulatory Model? Health Affairs, May/June 2006; 25(3): 707-719. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Drugs And Vaccines Around The World Health Affairs, March/April 2006; 25(2): 312 [Extract] [Full Text] [PDF] [Reprints & Permissions] David B. Ridley, Henry G. Grabowski, and Jeffrey L. Moe Developing Drugs For Developing Countries Health Affairs, March/April 2006; 25(2): 313-324. [Abstract] [Full Text] [Figures Only] [PDF] [Technical Appendix][Media/Policy Briefing][Interview with lead author] [Reprints & Permissions] Ramanan Laxminarayan, Mead Over, and David L. Smith Will A Global Subsidy Of New Antimalarials Delay The Emergence Of Resistance And Save Lives? Health Affairs, March/April 2006; 25(2): 325-336. [Abstract] [Full Text] [Figures Only] [PDF] [Online Appendices][Media/Policy Briefing] [Reprints & Permissions] Steven G. Morgan, Meghan McMahon, Craig Mitton, Elizabeth Roughead, Ray Kirk, Panos Kanavos, and Devidas Menon Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United Kingdom Health Affairs, March/April 2006; 25(2): 337-347. [Abstract] [Full Text] [PDF] [Online Supplement] [Reprints & Permissions] Bruce S. Manheim, Jr., Patricia Granahan, and Kenneth J. Dow ‘Follow-On Biologics’: Ensuring Continued Innovation In The Biotechnology Industry Health Affairs, March/April 2006; 25(2): 394-404. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Christopher P. Adams and Van V. Brantner Estimating The Cost Of New Drug Development: Is It Really $802 Million? Health Affairs, March/April 2006; 25(2): 420-428. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] David B. Ridley, Judith M. Kramer, Hugh H. Tilson, Henry G. Grabowski, and Kevin A. Schulman Spending On Postapproval Drug Safety Health Affairs, March/April 2006; 25(2): 429-436. [Abstract] [Full Text] [PDF] [Online Supplement] [Reprints & Permissions] Mireille Jacobson, A. James O’Malley, Craig C. Earle, Juliana Pakes, Peter Gaccione, and Joseph P. Newhouse Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients? Health Affairs, March/April 2006; 25(2): 437-443. [Abstract] [Full Text] [PDF] [Technical Appendix] [Reprints & Permissions] Henry G. Grabowski and Y. Richard Wang The Quantity And Quality Of Worldwide New Drug Introductions, 1982–2003 Health Affairs, March/April 2006; 25(2): 452-460. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Salomeh Keyhani, Marie Diener-West, and Neil Powe Are Development Times For Pharmaceuticals Increasing Or Decreasing? Health Affairs, March/April 2006; 25(2): 461-468. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Nancy E. Morden and Louis P. Garrison, Jr. Implications Of Part D For Mentally Ill Dual Eligibles: A Challenge For Medicare Health Affairs, March/April 2006; 25(2): 491-500. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Cynthia Smith, Cathy Cowan, Stephen Heffler, Aaron Catlin the National Health Accounts Team National Health Spending In 2004: Recent Slowdown Led By Prescription Drug Spending Health Affairs, January/February 2006; 25(1): 186-196. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Walid F. Gellad, Haiden A. Huskamp, Kathryn A. Phillips, and Jennifer S. Haas How The New Medicare Drug Benefit Could Affect Vulnerable Populations Health Affairs, January/February 2006; 25(1): 248-255. [Abstract] [Full Text] [PDF] [Online Appendix] [Reprints & Permissions] Daniel Carpenter, A Proposal For Financing Postmarketing Drug Safety Studies By Augmenting FDA User Fees, Health Affairs Web Exclusive, October 18, 2005 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Pamela Sankar and Jonathan Kahn, BiDil: Race Medicine Or Race Marketing?, Health Affairs Web Exclusive, October 11, 2005 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Rick J. Carlson, The Case Of BiDil: A Policy Commentary On Race And Genetics, Health Affairs Web Exclusive, October 11, 2005 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Douglas S. Bell and Maria A. Friedman E-Prescribing And The Medicare Modernization Act Of 2003 Health Affairs, September/October 2005; 24(5): 1159-1169. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Lawrence K. Gottlieb, Elliot M. Stone, Diane Stone, Lynne A. Dunbrack, and John Calladine Regulatory And Policy Barriers To Effective Clinical Data Exchange: Lessons Learned From MedsInfo-ED Health Affairs, September/October 2005; 24(5): 1197-1204. [Abstract] [Full Text] [PDF] [Online Supplemental Exhibit] [Reprints & Permissions] David J. Malenka, Aaron V. Kaplan, Sandra M. Sharp, and John E. Wennberg Postmarketing Surveillance Of Medical Devices Using Medicare Claims Health Affairs, July/August 2005; 24(4): 928-937. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Susan Chimonas and David J. Rothman New Federal Guidelines For Physician–Pharmaceutical Industry Relations: The Politics Of Policy Formation Health Affairs, July/August 2005; 24(4): 949-960. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Mary Ruggie Mainstreaming Complementary Therapies: New Directions In Health Care Health Affairs, July/August 2005; 24(4): 980-990. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Richard L. Nahin, Carol H. Pontzer, and Margaret A. Chesney Racing Toward The Integration Of Complementary And Alternative Medicine: A Marathon Or A Sprint? Health Affairs, July/August 2005; 24(4): 991-993. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bruce Stuart, Becky A. Briesacher, Dennis G. Shea, Barbara Cooper, Fatima S. Baysac, and M. Rhona Limcangco Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit Health Affairs, July/August 2005; 24(4): 1022-1031. [Abstract] [Full Text] [Figures Only] [PDF] [Erratum] [Reprints & Permissions] Nancy E. Morden and Sean D. Sullivan States’ Control Of Prescription Drug Spending: A Heterogeneous Approach Health Affairs, July/August 2005; 24(4): 1032-1038. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] William E. Encinosa, Didem M. Bernard, Claudia A. Steiner, and Chi-Chang Chen Use And Costs Of Bariatric Surgery And Prescription Weight-Loss Medications Health Affairs, July/August 2005; 24(4): 1039-1046. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Victoria G. Hale, Katherine Woo, and Helene Levens Lipton Oxymoron No More: The Potential Of Nonprofit Drug Companies To Deliver On The Promise Of Medicines For The Developing World Health Affairs, July/August 2005; 24(4): 1057-1063. [Abstract] [Full Text] [PDF] [Reprints & Permissions] C. Daniel Mullins, Andrea R. DeVries, Van Doren Hsu, Fanlun Meng, and Francis B. Palumbo Variability And Growth In Spending For Outpatient Specialty Pharmaceuticals Health Affairs, July/August 2005; 24(4): 1117-1127. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Bradley C. Strunk, Paul B. Ginsburg, and John P. Cookson, Tracking Health Care Costs: Declining Growth Trend Pauses In 2004, Health Affairs Web Exclusive, June 21, 2005 [Abstract] [PDF] [HTML Version][Interview] [Reprints & Permissions] Paul A. Offit Why Are Pharmaceutical Companies Gradually Abandoning Vaccines? Health Affairs, May/June 2005; 24(3): 622-630. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Stanley A. Plotkin Why Certain Vaccines Have Been Delayed Or Not Developed At All Health Affairs, May/June 2005; 24(3): 631-634. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Margaret S. Coleman, Nalinee Sangrujee, Fangjun Zhou, and Susan Chu Factors Affecting U.S. Manufacturers’ Decisions To Produce Vaccines Health Affairs, May/June 2005; 24(3): 635-642. [Abstract] [Full Text] [PDF] [Online Appendix] [Reprints & Permissions] Peter J. Cunningham Medicaid Cost Containment And Access To Prescription Drugs Health Affairs, May/June 2005; 24(3): 780-789. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Chris Koyanagi, Sandra Forquer, and Elaine Alfano Medicaid Policies To Contain Psychiatric Drug Costs Health Affairs, March/April 2005; 24(2): 536-544. [Abstract] [Full Text] [Figures Only] [PDF] [Supplemental Exhibit] [Reprints & Permissions] Ilavenil Ramiah and Michael R. Reich Public-Private Partnerships And Antiretroviral Drugs For HIV/AIDS: Lessons From Botswana Health Affairs, March/April 2005; 24(2): 545-551. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Daniel M. Fox Evidence Of Evidence-Based Health Policy: The Politics Of Systematic Reviews In Coverage Decisions Health Affairs, January/February 2005; 24(1): 114-122. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Mark Helfand Using Evidence Reports: Progress And Challenges In Evidence-Based Decision Making Health Affairs, January/February 2005; 24(1): 123-127. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Steven M. Teutsch, Marc L. Berger, and Milton C. Weinstein Comparative Effectiveness: Asking The Right Questions, Choosing The Right Method Health Affairs, January/February 2005; 24(1): 128-132. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Dan Mendelson and Tanisha V. Carino Evidence-Based Medicine In The United States—De Rigueur Or Dream Deferred? Health Affairs, January/February 2005; 24(1): 133-136. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Cynthia Smith, Cathy Cowan, Art Sensenig, Aaron Catlin, and the Health Accounts Team Health Spending Growth Slows In 2003 Health Affairs, January/February 2005; 24(1): 185-194. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Samuel H. Zuvekas Prescription Drugs And The Changing Patterns Of Treatment For Mental Disorders, 1996–2001 Health Affairs, January/February 2005; 24(1): 195-205. [Abstract] [Full Text] [PDF] [Reprints & Permissions] José A. Pagán and Mark V. Pauly Access To Conventional Medical Care And The Use Of Complementary And Alternative Medicine Health Affairs, January/February 2005; 24(1): 255-262. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Stanley S. Wallack, Dana Beth Weinberg, and Cindy Parks Thomas Health Plans’ Strategies To Control Prescription Drug Spending Health Affairs, November/December 2004; 23(6): 141-148. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Robert F. Atlas, The Role Of PBMs In Implementing The Medicare Prescription Drug Benefit, Health Affairs Web Exclusive, October 28, 2004 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Jennifer Christian-Herman, Matthew Emons, and Dorothy George, Effects Of Generic-Only Drug Coverage In A Medicare HMO, Health Affairs Web Exclusive, September 29, 2004 [Abstract] [PDF] [Methods Appendix][HTML Version] [Reprints & Permissions] Benjamin G. Druss, Steven C. Marcus, Mark Olfson, and Harold Alan Pincus Listening To Generic Prozac: Winners, Losers, And Sideliners Health Affairs, September/October 2004; 23(5): 210-216. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] John F. Moeller, G. Edward Miller, and Jessica S. Banthin Looking Inside The Nation’s Medicine Cabinet: Trends In Outpatient Drug Spending By Medicare Beneficiaries, 1997 And 2001 Health Affairs, September/October 2004; 23(5): 217-225. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Fadia T. Shaya, Steven Blume, and C. Daniel Mullins Prescription Drug Spending Trends For The Privately Insured In Maryland, 2000–2001 Health Affairs, September/October 2004; 23(5): 226-232. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Marta Wosinska and Robert S. Huckman, MarketWatch: Generic Dispensing And Substitution In Mail And Retail Pharmacies, Health Affairs Web Exclusive, July 28, 2004 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Gerard F. Anderson, Dennis G. Shea, Peter S. Hussey, Salomeh Keyhani, and Laurie Zephyrin, MarketWatch: Doughnut Holes And Price Controls, Health Affairs Web Exclusive, July 21, 2004 [Abstract] [PDF] [HTML Version][Related Paper] [Reprints & Permissions] Patricia M. Danzon, From The Field: Closing The Doughnut Hole: No Easy Answers, Health Affairs Web Exclusive, July 21, 2004 [Abstract] [PDF] [HTML Version][Related Paper] [Reprints & Permissions] Kimberly A. Kaphingst and William DeJong The Educational Potential Of Direct-To-Consumer Prescription Drug Advertising Health Affairs, July/August 2004; 23(4): 143-150. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Peter Stein and Ernst Valery Competition: An Antidote To The High Price Of Prescription Drugs Health Affairs, July/August 2004; 23(4): 151-158. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Thomas S. Rector and Patricia J. Venus Do Drug Benefits Help Medicare Beneficiaries Afford Prescribed Drugs? Health Affairs, July/August 2004; 23(4): 213-222. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bradley C. Strunk and Paul B. Ginsburg, Trends: Tracking Health Care Costs: Trends Turn Downward In 2003, Health Affairs Web Exclusive, June 9, 2004 [Abstract] [PDF] [HTML Version][View Webcast With The Authors] [Reprints & Permissions] Douglas S. Bell, Richard S. Marken, Robin C. Meili, C. Jason Wang, Mayde Rosen, Robert H. Brook, and RAND Electronic Prescribing Expert Advisory Panel , Recommendations For Comparing Electronic Prescribing Systems: Results Of An Expert Consensus Process, Health Affairs Web Exclusive, May 25, 2004 [Abstract] [PDF] [HTML Version][Supplemental Exhibit][Related Papers] [Reprints & Permissions] David J. Brailer, Perspective: Translating Ideals For Health Information Technology Into Practice, Health Affairs Web Exclusive, May 25, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Jonathan C. Javitt, Perspective: How To Succeed In Health Information Technology, Health Affairs Web Exclusive, May 25, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] W. Ed Hammond, Perspective: The Role Of Standards In Electronic Prescribing, Health Affairs Web Exclusive, May 25, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] John H. Barton TRIPS And The Global Pharmaceutical Market Health Affairs, May/June 2004; 23(3): 146-154. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Amir Attaran How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? Health Affairs, May/June 2004; 23(3): 155-166. [Abstract] [Full Text] [Figures Only] [PDF] [Supplemental Exhibit] [Reprints & Permissions] J.D. Kleinke Think Globally, Protect Locally: A Conversation With Mark McClellan Health Affairs, May/June 2004; 23(3): 177-185. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Steven Morgan, Ken Bassett, and Barbara Mintzes Outcomes-Based Drug Coverage in British Columbia Health Affairs, May/June 2004; 23(3): 269-276. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Joel S. Weissman, David Blumenthal, Alvin J. Silk, Michael Newman, Kinga Zapert, Robert Leitman, and Sandra Feibelmann, Physicians Report On Patient Encounters Involving Direct-To-Consumer Advertising, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Steven Woloshin, Lisa M. Schwartz, and H. Gilbert Welch, The Value Of Benefit Data In Direct-To-Consumer Drug Ads, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers][Sample Drug Ads] [Reprints & Permissions] Pat Kelly, Perspective: DTC Advertising’s Benefits Far Outweigh Its Imperfections, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] David L. Riggs, Stacy M. Holdsworth, and David R. McAvoy, Perspective: Direct-To-Consumer Advertising: Developing Evidence-Based Policy To Improve Retention And Comprehension, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] James M. Jeffords, Perspective: Direct-To-Consumer Drug Advertising: You Get What You Pay For, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Henry A. Waxman, Perspective: Ensuring That Consumers Receive Appropriate Information From Drug Ads: What Is The FDA’s Role?, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Peter J. Pitts, Perspective: Turning Point Or Tipping Point: New FDA Draft Guidances And The Future Of DTC Advertising, Health Affairs Web Exclusive, April 28, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Juliette Cubanski, Richard G. Frank, and Arnold M. Epstein, Savings From Drug Discount Cards: Relief For Medicare Beneficiaries?, Health Affairs Web Exclusive, April 14, 2004 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Jalpa A. Doshi, Nicole Brandt, and Bruce Stuart, The Impact Of Drug Coverage On COX-2 Inhibitor Use In Medicare, Health Affairs Web Exclusive, February 18, 2004 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Stephen Heffler, Sheila Smith, Sean Keehan, M. Kent Clemens, Mark Zezza, and Christopher Truffer, Health Spending Projections Through 2013, Health Affairs Web Exclusive, February 11, 2004 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Mary K. Olson, Perspective: Explaining Reductions In FDA Drug Review Times: PDUFA Matters, Health Affairs Web Exclusive, January 30, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Daniel P. Carpenter, Perspective: Defending Submission-Year Analyses Of New Drug Approvals, Health Affairs Web Exclusive, January 30, 2004 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Iain M. Cockburn The Changing Structure Of The Pharmaceutical Industry Health Affairs, January/February 2004; 23(1): 10-22. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Thomas W. Croghan and Patricia M. Pittman The Medicine Cabinet: What’s In It, Why, And Can We Change The Contents? Health Affairs, January/February 2004; 23(1): 23-33. [Abstract] [Full Text] [PDF] [Reprints & Permissions] J.D. Kleinke Access Versus Excess: Value-Based Cost Sharing For Prescription Drugs Health Affairs, January/February 2004; 23(1): 34-47. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Fabio Pammolli and Massimo Riccaboni Market Structure And Drug Innovation Health Affairs, January/February 2004; 23(1): 48-50. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Daniel P. Carpenter The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy Health Affairs, January/February 2004; 23(1): 52-63. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Eric G. Campbell, Joshua B. Powers, David Blumenthal, and Brian Biles Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences Health Affairs, January/February 2004; 23(1): 64-76. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Robert M. Califf Defining The Balance Of Risk And Benefit In The Era Of Genomics And Proteomics Health Affairs, January/February 2004; 23(1): 77-87. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Joseph P. Newhouse How Much Should Medicare Pay For Drugs? Health Affairs, January/February 2004; 23(1): 89-102. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Ernst R. Berndt Unique Issues Raised By Drug Benefit Design Health Affairs, January/February 2004; 23(1): 103-106. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Uwe E. Reinhardt An Information Infrastructure For The Pharmaceutical Market Health Affairs, January/February 2004; 23(1): 107-112. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Mark V. Pauly Medicare Drug Coverage And Moral Hazard Health Affairs, January/February 2004; 23(1): 113-122. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Peter J. Neumann Evidence-Based And Value-Based Formulary Guidelines Health Affairs, January/February 2004; 23(1): 124-134. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Stephen B. Soumerai Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid Health Affairs, January/February 2004; 23(1): 135-146. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Cynthia Smith Retail Prescription Drug Spending In The National Health Accounts Health Affairs, January/February 2004; 23(1): 160-167. [Abstract] [Full Text] [Figures Only] [PDF] [Erratum] [Reprints & Permissions] Jesse D. Malkin, Dana P. Goldman, and Geoffrey F. Joyce The Changing Face Of Pharmacy Benefit Design Health Affairs, January/February 2004; 23(1): 194-199. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Janet R. Gilsdorf As Drug Marketing Pays Off, My Mother Pays Up Health Affairs, January/February 2004; 23(1): 208-212. [Extract] [Full Text] [PDF] [Reprints & Permissions] Buck Taylor Giveaway Drugs: Good Intentions, Bad Design Health Affairs, January/February 2004; 23(1): 213-217. [Extract] [Full Text] [PDF] [Reprints & Permissions] Bruce E. Landon, James D. Reschovsky, and David Blumenthal Physicians’ Views Of Formularies: Implications For Medicare Drug Benefit Design Health Affairs, January/February 2004; 23(1): 218-226. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Sachin Kamal-Bahl and Becky Briesacher How Do Incentive-Based Formularies Influence Drug Selection And Spending For Hypertension? Health Affairs, January/February 2004; 23(1): 227-236. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John F. Hoadley The Continued Need For Independent Research On Prescription Drugs Health Affairs, January/February 2004; 23(1): 244-249. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Daniel Carpenter, Michael Chernew, Dean G. Smith, and A. Mark Fendrick, Approval Times For New Drugs: Does The Source Of Funding For FDA Staff Matter?, Health Affairs Web Exclusive, December 17, 2003 [Abstract] [PDF] [HTML Version][Related Papers] [Reprints & Permissions] Uwe E. Reinhardt The Medicare World From Both Sides: A Conversation With Tom Scully Health Affairs, November/December 2003; 22(6): 167-174. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Haiden A. Huskamp Managing Psychotropic Drug Costs: Will Formularies Work? Health Affairs, September/October 2003; 22(5): 84-96. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Richard M. Scheffler and Paul B. Kirby The Occupational Transformation Of The Mental Health System Health Affairs, September/October 2003; 22(5): 177-188. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] K. Tom Xu Financial Disparities In Prescription Drug Use Between Elderly And Nonelderly Americans Health Affairs, September/October 2003; 22(5): 210-221. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bruce Stuart, Puneet K. Singhal, Cheryl Fahlman, Jalpa Doshi, and Becky Briesacher, Employer-Sponsored Health Insurance And Prescription Drug Coverage For New Retirees: Dramatic Declines In Five Years, Health Affairs Web Exclusive, July 23, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] John K. Iglehart Good Science And The Marketplace For Drugs: A Conversation With Jean-Pierre Garnier Health Affairs, July/August 2003; 22(4): 119-127. [Extract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] The Reforming States Group State Initiatives On Prescription Drugs: Creating A More Functional Market Health Affairs, July/August 2003; 22(4): 128-136. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Vicki A. Freedman and Hakan Aykan Trends In Medication Use And Functioning Before Retirement Age: Are They Linked? Health Affairs, July/August 2003; 22(4): 154-162. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Ramin Mojtabai and Mark Olfson Medication Costs, Adherence, And Health Outcomes Among Medicare Beneficiaries Health Affairs, July/August 2003; 22(4): 220-229. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Panos Kanavos and Uwe Reinhardt Reference Pricing For Drugs: Is It Compatible With U.S. Health Care? Health Affairs, May/June 2003; 22(3): 16-30. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Alan Maynard and Karen Bloor Dilemmas In Regulation Of The Market For Pharmaceuticals Health Affairs, May/June 2003; 22(3): 31-41. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Steven G. Morgan, Morris L. Barer, and Jonathan D. Agnew Whither Seniors’ Pharmacare: Lessons From (And For) Canada Health Affairs, May/June 2003; 22(3): 49-59. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Haiden A. Huskamp, Arnold M. Epstein, and David Blumenthal The Impact Of A National Prescription Drug Formulary On Prices, Market Share, And Spending: Lessons For Medicare? Health Affairs, May/June 2003; 22(3): 149-158. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Benjamin M. Craig, David H. Kreling, and David A. Mott Do Seniors Get The Medicines Prescribed For Them? Evidence From The 1996–1999 Medicare Current Beneficiary Survey Health Affairs, May/June 2003; 22(3): 175-182. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Joel S. Weissman, David Blumenthal, Alvin J. Silk, Kinga Zapert, Michael Newman, and Robert Leitman, Consumers' Reports On The Health Effects Of Direct-To-Consumer Drug Advertising, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Robert W. Dubois, Pharmaceutical Promotion: Don't Throw The Baby Out With The Bathwater, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Jerry Avorn, Perspective: Advertising And Prescription Drugs: Promotion, Education, And The Public's Health, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Elaine Batchlor and Marianne Laouri, Perspective: Pharmaceutical Promotion, Advertising, And Consumers, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Thomas Bodenheimer, Perspective: Two Advertisements For TV Drug Ads, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] John E. Calfee, What Do We Know About Direct-To-Consumer Advertising Of Prescription Drugs?, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Martin T. Gahart, Louise M. Duhamel, Anne Dievler, and Roseanne Price, Examining The FDA's Oversight Of Direct-To-Consumer Advertising, Health Affairs Web Exclusive, February 26, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Stephen Heffler, Sheila Smith, Sean Keehan, M. Kent Clemens, Greg Won, and Mark Zezza, Health Spending Projections For 2002-2012, Health Affairs Web Exclusive, February 7, 2003 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Norman Daniels, J. Russell Teagarden, and James E. Sabin An Ethical Template For Pharmacy Benefits Health Affairs, January/February 2003; 22(1): 125-137. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Katharine Levit, Cynthia Smith, Cathy Cowan, Helen Lazenby, Art Sensenig, and Aaron Catlin Trends In U.S. Health Care Spending, 2001 Health Affairs, January/February 2003; 22(1): 154-164. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Cindy Parks Thomas, Stanley S. Wallack, Sue Lee, and Grant A. Ritter, Impact Of Health Plan Design And Management On Retirees' Prescription Drug Use And Spending, 2001, Health Affairs Web Exclusive, December 4, 2002 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Bradley C. Strunk, Paul B. Ginsburg, and Jon R. Gabel, Tracking Health Care Costs: Growth Accelerates Again In 2001, Health Affairs Web Exclusive, September 25, 2002 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Judith A. Cooksey, Katherine K. Knapp, Surrey M. Walton, and James M. Cultice Challenges To The Pharmacist Profession From Escalating Pharmaceutical Demand Health Affairs, September/October 2002; 21(5): 182-188. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Suzanne Felt-Lisk, Megan McHugh, and Embry Howell Monitoring Local Safety-Net Providers: Do They Have Adequate Capacity? Health Affairs, September/October 2002; 21(5): 277-283. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Dana Gelb Safran, Patricia Neuman, Cathy Schoen, Jana E. Montgomery, Wenjun Li, Ira B. Wilson, Michelle S. Kitchman, Andrea E. Bowen, and William H. Rogers, Prescription Drug Coverage And Seniors: How Well Are States Closing The Gap?, Health Affairs Web Exclusive, July 31, 2002 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] John A. Robertson, Baruch Brody, Allen Buchanan, Jeffrey Kahn, and Elizabeth McPherson Pharmacogenetic Challenges For The Health Care System Health Affairs, July/August 2002; 21(4): 155-167. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Catharine W. Burt National Trends In Use Of Medications In Office-Based Practice, 1985–1999 Health Affairs, July/August 2002; 21(4): 206-214. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Uwe E. Reinhardt, Peter S. Hussey, and Gerard F. Anderson Cross-National Comparisons Of Health Systems Using OECD Data, 1999 Health Affairs, May/June 2002; 21(3): 169-181. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Paul Jung No Free Lunch Health Affairs, March/April 2002; 21(2): 226-231. [Extract] [Full Text] [PDF] [Reprints & Permissions] Howard Brody A Matter Of Influence Health Affairs, March/April 2002; 21(2): 232-234. [Extract] [Full Text] [PDF] [Reprints & Permissions] Frank Davidoff Between The Lines: Navigating The Uncharted Territory Of Industry-Sponsored Research Health Affairs, March/April 2002; 21(2): 235-242. [Extract] [Full Text] [PDF] [Reprints & Permissions] Bert Spilker The Benefits And Risks Of A Pack Of M&Ms Health Affairs, March/April 2002; 21(2): 243-244. [Extract] [Full Text] [PDF] [Reprints & Permissions] Mary A. Laschober, Michelle Kitchman, Patricia Neuman, and Allison A. Strabic, Trends In Medicare Supplemental Insurance And Prescription Drug Coverage, 1996-1999, Health Affairs Web Exclusive, February 27, 2002 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] Katharine Levit, Cynthia Smith, Cathy Cowan, Helen Lazenby, and Anne Martin Inflation Spurs Health Spending In 2000 Health Affairs, January/February 2002; 21(1): 172-181. [Extract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Robert W. Dubois, Elaine Batchlor, and Sally Wade Geographic Variation In The Use Of Medications: Is Uniformity Good News Or Bad? Health Affairs, January/February 2002; 21(1): 240-250. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bradley C. Strunk, Paul Ginsburg, and Jon Gabel, Tracking Health Care Costs, Health Affairs Web Exclusive, September 26, 2001 [Abstract] [PDF] [HTML Version] [Reprints & Permissions] David M. Cutler and Mark McClellan Is Technological Change In Medicine Worth It? Health Affairs, September/October 2001; 20(5): 11-29. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Victor R. Fuchs and Harold C. Sox, Jr. Physicians’ Views Of The Relative Importance Of Thirty Medical Innovations Health Affairs, September/October 2001; 20(5): 30-42. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] J.D. Kleinke The Price Of Progress: Prescription Drugs In The Health Care Market Health Affairs, September/October 2001; 20(5): 43-60. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Alan M. Garber Evidence-Based Coverage Policy Health Affairs, September/October 2001; 20(5): 62-82. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Patricia M. Danzon and Mark V. Pauly Insurance And New Technology: From Hospital To Drugstore Health Affairs, September/October 2001; 20(5): 86-100. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Rebecca S. Eisenberg The Shifting Functional Balance Of Patents And Drug Regulation Health Affairs, September/October 2001; 20(5): 119-135. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Uwe E. Reinhardt Perspectives On The Pharmaceutical Industry Health Affairs, September/October 2001; 20(5): 136-149. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel The Ethics Of Pharmaceutical Benefit Management Health Affairs, September/October 2001; 20(5): 150-163. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Darren E. Zinner Medical R&D At The Turn Of The Millennium Health Affairs, September/October 2001; 20(5): 202-209. [Extract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] C. Daniel Mullins, Junling Wang, Francis B. Palumbo, and Bruce Stuart The Impact Of Pipeline Drugs On Drug Spending Growth Health Affairs, September/October 2001; 20(5): 210-215. [Extract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] F.M. Scherer The Link Between Gross Profitability And Pharmaceutical R&D Spending Health Affairs, September/October 2001; 20(5): 216-220. [Extract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Frank R. Lichtenberg Probing The Link Between Gross Profitability And R&D Spending Health Affairs, September/October 2001; 20(5): 221-222. [Extract] [Full Text] [PDF] [Reprints & Permissions] Jane Tilly and Joshua M. Wiener State Pharmaceutical Assistance Programs For Older And Disabled Americans Health Affairs, September/October 2001; 20(5): 223-232. [Extract] [Full Text] [PDF] [Reprints & Permissions] Frank R. Lichtenberg Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPS Health Affairs, September/October 2001; 20(5): 241-251. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Cindy Parks Thomas, Grant Ritter, and Stanley S. Wallack Growth In Prescription Drug Spending Among Insured Elders Health Affairs, September/October 2001; 20(5): 265-277. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Devidas Menon Pharmaceutical Cost Control In Canada: Does It Work? Health Affairs, May/June 2001; 20(3): 92-103. [Abstract] [Full Text] [PDF] [Reprints & Permissions] John A. Poisal and Lauren Murray Growing Differences Between Medicare Beneficiaries With And Without Drug Coverage Health Affairs, March/April 2001; 20(2): 74-85. [Abstract] [Full Text] [PDF] [Reprints & Permissions] Bruce Stuart, Dennis Shea, and Becky Briesacher Dynamics In Drug Coverage Of Medicare Beneficiaries: Finders, Losers, Switchers Health Affairs, March/April 2001; 20(2): 86-99. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Ernst R. Berndt The U.S. Pharmaceutical Industry: Why Major Growth In Times Of Cost Containment? Health Affairs, March/April 2001; 20(2): 100-114. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Richard G. Frank Prescription Drug Prices: Why Do Some Pay More Than Others Do? Health Affairs, March/April 2001; 20(2): 115-128. [Abstract] [Full Text] [Figures Only] [PDF] [Reprints & Permissions] Thomas W. Croghan The Controversy Of Increased Spending For Antidepressants Health Affairs, March/April 2001; 20(2): 129-135. [Extract] [Full Text] [PDF] [Reprints & Permissions] Alyce S. Adams, Stephen B. Soumerai, and Dennis Ross-Degnan Use Of Antihypertensive Drugs By Medicare Enrollees: Does Type Of Drug Coverage Matter? Health Affairs, January/February 2001; 20(1): 276-286. [Abstract] [Full Text] [PDF] [Reprints & Permissions] M Chernew, M E Cowen, D M Kirking, D G Smith, P Valenstein, and A M Fendrick Pharmaceutical cost growth under capitation: a case study Health Affairs, November/December 2000; 19(6): 266-276. [Abstract] [PDF] [Reprints & Permissions] P J Neumann, K Claxton, and M C Weinstein The FDA's regulation of health economic information Health Affairs, September/October 2000; 19(5): 129-137. [Abstract] [PDF] [Reprints & Permissions] S M Foote and L Etheredge Increasing use of new prescription drugs: a case study Health Affairs, July/August 2000; 19(4): 165-170. [PDF] [Reprints & Permissions] J M Mitchell and K H Anderson Effects of case management and new drugs on Medicaid AIDS spending Health Affairs, July/August 2000; 19(4): 233-243. [Abstract] [PDF] [Reprints & Permissions] D A Freund, D Willison, G Reeher, J Cosby, A Ferraro, and B O'Brien Outpatient pharmaceuticals and the elderly: policies in seven nations Health Affairs, May/June 2000; 19(3): 259-266. [PDF] [Reprints & Permissions] H A Huskamp, M B Rosenthal, R G Frank, and J P Newhouse The Medicare prescription drug benefit: how will the game be played? Health Affairs, March/April 2000; 19(2): 8-23. [Abstract] [PDF] [Reprints & Permissions] Patricia M. Danzon Perspective: Pharmaceutical Benefit Management: An Alternative Approach Health Affairs, March/April 2000; 19(2): 24-25. [PDF] [Reprints & Permissions] M McClellan, I D Spatz, and S Carney Designing a Medicare prescription drug benefit: issues, obstacles, and opportunities Health Affairs, March/April 2000; 19(2): 26-41. [Abstract] [PDF] [Reprints & Permissions] H L Lipton, D J Gross, M R Stebbins, and L H Syed Managing the pharmacy benefit in Medicare HMOs: what do we really know? Health Affairs, March/April 2000; 19(2): 42-58. [Abstract] [PDF] [Reprints & Permissions] Lee N. Newcomer Perspective: Medicare Pharmacy Coverage: Ensuring Safety Before Funding Health Affairs, March/April 2000; 19(2): 59-62. [PDF] [Reprints & Permissions] D W Moran Prescription drugs and managed care: can 'free-market detente' hold? Health Affairs, March/April 2000; 19(2): 63-77. [Abstract] [PDF] [Reprints & Permissions] J D Kleinke Just what the HMO ordered: the paradox of increasing drug costs Health Affairs, March/April 2000; 19(2): 78-91. [Abstract] [PDF] [Reprints & Permissions] P J Neumann, E A Sandberg, C M Bell, P W Stone, and R H Chapman Are pharmaceuticals cost-effective? A review of the evidence Health Affairs, March/April 2000; 19(2): 92-109. [Abstract] [PDF] [Reprints & Permissions] M S Wilkes, R A Bell, and R L Kravitz Direct-to-consumer prescription drug advertising: trends, impact, and implications Health Affairs, March/April 2000; 19(2): 110-128. [Abstract] [PDF] [Reprints & Permissions] R A Rettig The industrialization of clinical research Health Affairs, March/April 2000; 19(2): 129-146. [Abstract] [PDF] [Reprints & Permissions] A Keith The economics of Viagra Health Affairs, March/April 2000; 19(2): 147-157. [PDF] [Reprints & Permissions] S Levine, D Campen, M Millares, and A Barrueta Kaiser Permanente's prescription drug benefit Health Affairs, March/April 2000; 19(2): 185-190. [PDF] [Reprints & Permissions] E P Steinberg, B Gutierrez, A Momani, J A Boscarino, P Neuman, and P Deverka Beyond survey data: a claims-based analysis of drug use and spending by the elderly Health Affairs, March/April 2000; 19(2): 198-211. [Abstract] [PDF] [Reprints & Permissions] S Christensen and J Wagner The costs of a Medicare prescription drug benefit Health Affairs, March/April 2000; 19(2): 212-218. [Abstract] [PDF] [Reprints & Permissions] J Blustein Drug coverage and drug purchases by Medicare beneficiaries with hypertension Health Affairs, March/April 2000; 19(2): 219-230. [Abstract] [PDF] [Reprints & Permissions] R W Dubois, A J Chawla, C A Neslusan, M W Smith, and S Wade Explaining drug spending trends: does perception match reality? Health Affairs, March/April 2000; 19(2): 231-239. [Abstract] [PDF] [Reprints & Permissions] K Titlow, L Randel, C M Clancy, and E J Emanuel Drug coverage decisions: the role of dollars and values Health Affairs, March/April 2000; 19(2): 240-247. [Abstract] [PDF] [Reprints & Permissions] J A Poisal and G S Chulis Medicare beneficiaries and drug coverage Health Affairs, March/April 2000; 19(2): 248-256. [Abstract] [PDF] [Reprints & Permissions] J B Sardis Pills, policies, and patients Health Affairs, September/October 1999; 18(5): 156-162. [PDF] [Reprints & Permissions] John Rother Perspective: A Drug Benefit: The Necessary Prescription For Medicare Health Affairs, July/August 1999; 18(4): 20-22. [PDF] [Reprints & Permissions] C Huttin Drug price divergence in Europe: regulatory aspects Health Affairs, May/June 1999; 18(3): 245-249. [PDF] [Reprints & Permissions] R A Merrill Modernizing the FDA: an incremental revolution Health Affairs, March/April 1999; 18(2): 96-111. [Abstract] [PDF] [Reprints & Permissions] S Glied and M Stabile Covering older Americans: forecast for the next decade Health Affairs, January/February 1999; 18(1): 208-213. [PDF] [Reprints & Permissions] M Davis, J Poisal, G Chulis, C Zarabozo, and B Cooper Prescription drug coverage, utilization, and spending among Medicare beneficiaries Health Affairs, January/February 1999; 18(1): 231-243. [Abstract] [PDF] [Reprints & Permissions] P J Neumann and E A Sandberg Trends in health care R&D and technology innovation Health Affairs, November/December 1998; 17(6): 111-119. [PDF] [Reprints & Permissions] A Lyles, I H Zuckerman, S M DeSipio, and T Fulda When warnings are not enough: primary prevention through drug use review Health Affairs, September/October 1998; 17(5): 175-183. [PDF] [Reprints & Permissions] J E McDonough Tracking the demise of state hospital rate setting Health Affairs, January/February 1997; 16(1): 142-149. [Abstract] [PDF] [Reprints & Permissions] B R Luce, C A Lyles, and A M Rentz The view from managed care pharmacy Health Affairs, Winter 1996; 15(4): 168-176. [Abstract] [PDF] [Reprints & Permissions] P J Neumann, D E Zinner, and A D Paltiel The FDA and regulation of cost-effectiveness claims Health Affairs, Fall 1996; 15(3): 54-71. [Abstract] [PDF] [Reprints & Permissions] B L Walser, D Ross-Degnan, and S B Soumerai Do open formularies increase access to clinically useful drugs? Health Affairs, Fall 1996; 15(3): 95-109. [Abstract] [PDF] [Reprints & Permissions] John Hutton and Bryan R. Luce Pharmaceutical Regulation In Spain Health Affairs, Spring 1995; 14(1): 323 [PDF] [Reprints & Permissions] K R Levit, C A Cowan, H C Lazenby, P A McDonnell, A L Sensenig, J M Stiller, and D K Won National health spending trends, 1960-1993 Health Affairs, Winter 1994; 13(5): 14-31. [Abstract] [PDF] [Reprints & Permissions] R A Merrill Regulation of drugs and devices: an evolution Health Affairs, Summer 1994; 13(3): 47-69. [Abstract] [PDF] [Reprints & Permissions] W B Schwartz In the pipeline: a wave of valuable medical technology Health Affairs, Summer 1994; 13(3): 70-79. [Abstract] [PDF] [Reprints & Permissions] J Hutton, M Borowitz, I Oleksy, and B R Luce The pharmaceutical industry and health reform: lessons from Europe Health Affairs, Summer 1994; 13(3): 98-111. [Abstract] [PDF] [Reprints & Permissions] Richard J. Kogan Why We Must Preserve Drug Innovation Health Affairs, Summer 1994; 13(3): 278-279. [Reprints & Permissions] S H Long Prescription drugs and the elderly: issues and options Health Affairs, Supplement 1994; 13(2): 157-174. [Abstract] [PDF] [Reprints & Permissions] G J Mossinghoff Pharmaceutical companies as a positive force for change Health Affairs, Fall 1993; 12(3): 148-149. [PDF] [Reprints & Permissions] Fredrik Andersson Discourse On GAO Drug Price Comparisons Health Affairs, Summer 1993; 12(2): 220-221. [Reprints & Permissions] M F Drummond Basing prescription drug payment on economic analysis: the case of Australia Health Affairs, Winter 1992; 11(4): 191-196. [PDF] [Reprints & Permissions] B S Bloom Issues in mandatory economic assessment of pharmaceuticals Health Affairs, Winter 1992; 11(4): 197-201. [PDF] [Reprints & Permissions] D A Freund, D Evans, D Henry, and R Dittus Implications of the Australian guidelines for the United States Health Affairs, Winter 1992; 11(4): 202-206. [PDF] [Reprints & Permissions] Daniel X. Freedman and Stephen M. Stahl Perspectives: Pharmacology: Policy Implications Of New Psychiatric Drugs Health Affairs, Fall 1992; 11(3): 157-163. [PDF] [Reprints & Permissions] Nancy J.W. Lewis, William F. McGhan, and Albert I. Wertheimer Drug Rebates Revisited Health Affairs, Spring 1992; 11(1): 286 [Reprints & Permissions] Michael R. Pollard and John M. Coster The Politics Of Drug Policy Health Affairs, Spring 1992; 11(1): 287 [Reprints & Permissions] M L Burstall Europe after 1992: implications for pharmaceuticals Health Affairs, Fall 1991; 10(3): 157-171. [PDF] [Reprints & Permissions] M Anderson and J Dunn Disclosure of outpatient prescription drug benefits in HMOs Health Affairs, Summer 1991; 10(2): 143-147. [PDF] [Reprints & Permissions] M R Pollard and J M Coster Savings for Medicaid drug spending Health Affairs, Summer 1991; 10(2): 196-206. [PDF] [Reprints & Permissions] J P Weiner, A Lyles, D M Steinwachs, and K C Hall Impact of managed care on prescription drug use Health Affairs, Spring 1991; 10(1): 140-154. [PDF] [Reprints & Permissions] John F. Moeller Correcting Errors In Prescription Drug Reporting: A Critique Health Affairs, Spring 1991; 10(1): 210-211. [PDF] [Reprints & Permissions] Frederick H. Lowy and Jack Ivan Williams Prescription Drug Policy: A Canadian Perspective Health Affairs, Spring 1991; 10(1): 215-217. [Reprints & Permissions] Theodore Cooper The Pharmaceutical Industry: A National Resource Health Affairs, Winter 1990; 9(4): 222-223. [PDF] [Reprints & Permissions] Gail R. Wilensky Achieving Prescription Drug Savings Health Affairs, Winter 1990; 9(4): 222 [PDF] [Reprints & Permissions] J Avorn The elderly and drug policy: coming of age Health Affairs, Fall 1990; 9(3): 6-19. [PDF] [Reprints & Permissions] R J Lavizzo-Mourey and J M Eisenberg Prescription drugs, practicing physicians, and the elderly Health Affairs, Fall 1990; 9(3): 20-35. [PDF] [Reprints & Permissions] M R Pollard Managed care and a changing pharmaceutical industry Health Affairs, Fall 1990; 9(3): 55-65. [PDF] [Reprints & Permissions] C Horgan, B Goody, D Knapp, and L Fitterman The role of mail service pharmacies Health Affairs, Fall 1990; 9(3): 66-74. [PDF] [Reprints & Permissions] T Rice, K Desmond, and J Gabel The Medicare Catastrophic Coverage Act: a post-mortem Health Affairs, Fall 1990; 9(3): 75-87. [PDF] [Reprints & Permissions] C L Schur, M L Berk, and P Mohr Understanding the cost of a catastrophic drug benefit Health Affairs, Fall 1990; 9(3): 88-100. [PDF] [Reprints & Permissions] D Pryor A prescription for high drug prices Health Affairs, Fall 1990; 9(3): 101-109. [PDF] [Reprints & Permissions] P E Freiman New drug legislation: a response from the pharmaceutical industry Health Affairs, Fall 1990; 9(3): 110-113. [PDF] [Reprints & Permissions] W A Ray, M R Griffin, and R I Shorr Adverse drug reactions and the elderly Health Affairs, Fall 1990; 9(3): 114-122. [PDF] [Reprints & Permissions] S W Schondelmeyer and J Thomas, III Trends in retail prescription expenditures Health Affairs, Fall 1990; 9(3): 131-145. [PDF] [Reprints & Permissions] M L Berk, C L Schur, and P Mohr Using survey data to estimate prescription drug costs Health Affairs, Fall 1990; 9(3): 146-156. [PDF] [Reprints & Permissions] J F Beary Geriatric medications in the pipeline Health Affairs, Fall 1990; 9(3): 157-160. [PDF] [Reprints & Permissions] J W Rowe Foundations' role in improving medication use by older persons Health Affairs, Fall 1990; 9(3): 176-178. [PDF] [Reprints & Permissions] Linda G. Greenberg Funding And Research Programs In Medications And The Elderly Health Affairs, Fall 1990; 9(3): 179-182. [PDF] [Reprints & Permissions] Prescription Drugs And The Elderly Health Affairs, Fall 1990; 9(3): 191-194. [PDF] [Reprints & Permissions] M Gold, M Joffe, T L Kennedy, and A M Tucker Pharmacy benefits in health maintenance organizations Health Affairs, Fall 1989; 8(3): 182-190. [PDF] [Reprints & Permissions] H Grabowski Medicaid patients' access to new drugs Health Affairs, Winter 1988; 7(5): 102-114. [PDF] [Reprints & Permissions] Linda J. Blumberg and Gail R. Wilensky Conference Summary: Pharmaceuticals In Developing Countries Health Affairs, Fall 1988; 7(4): 175-179. [PDF] [Reprints & Permissions] J L Read and P M Campbell Health care innovation: a progress report Health Affairs, Summer 1988; 7(3): 174-185. [PDF] [Reprints & Permissions] M R Pollard and G S Persinger Investment in health care innovation Health Affairs, Summer 1987; 6(2): 93-106. [PDF] [Reprints & Permissions] I Lerner Pharmaceutical research: how America loses or wins Health Affairs, Summer 1986; 5(2): 116-120. [PDF] [Reprints & Permissions] J Avorn Drug innovation and public policy: some speculations Health Affairs, Summer 1986; 5(2): 121-127. [PDF] [Reprints & Permissions] M R Pollard, G S Persinger, and J G Perpich Technology innovation in health care Health Affairs, Summer 1986; 5(2): 135-147. [PDF] [Reprints & Permissions] J K White Health care innovation in an era of cost containment Health Affairs, Summer 1985; 4(2): 105-118. [PDF] [Reprints & Permissions] J Avorn Drug policy in the aging society Health Affairs, Fall 1983; 2(3): 23-32. [PDF] [Reprints & Permissions] B E Cabana Mental health and the elderly: new biopharmaceutic considerations Health Affairs, Fall 1983; 2(3): 33-38. [PDF] [Reprints & Permissions] James S. Turner Consumers, Computers, And Pharmaceuticals Health Affairs, Spring 1983; 2(1): 50-65. [PDF] [Reprints & Permissions]

Sign up for Collection Alerts Collected Resources Home Related collections: Access To Care AIDS/HIV Bioterrorism Business Of Health Cardiovascular Disease Chronic Care Complementary And Alternative Medicine Consumer Issues Demography Determinants Of Health Elderly Ethical Issues Evidence-Based Medicine Health Information Technology Health Philanthropy Health Professions Education Health Promotion/Disease Prevention Health Reform Health Spending Home Care Hospitals Insurance Market Insurance International Issues Internet And Health Legal/Regulatory Issues Long-Term Care Managed Care Managed Competition Maternal And Child Health Media Medicaid Medicare Mental Health/Substance Abuse Military Medicine Minority Health Nonprofit/For-Profit Status Nurses Oral Health Care Personal Experience ("Narrative Matters") Pharmaceuticals Physicians Politics Public Health Public Opinion Quality Of Care Report From The Field Research And Technology Rural Health Care Safety-Net Systems State/Local Issues - California State/Local Issues Vaccines Variations Workforce Issues